Incisive Genetics Raises $2.5M in Seed Funding
- Incisive Genetics, a Vancouver BC-based held biotech company, raised $2.5M in seed funding
- The round was led by investors Noel Hall and Sandra MacPherson of the MacHall group and Haig Farris, OC
- The company intends to use the funds to develop its manufacturing process and capabilities, advance key studies to enhance its gene editing delivery platform technology
- Established in 2018 and led by Dr. Blair R. Leavitt, IncisiveGenetics provides a non-viral delivery platform for genetic therapies
- This delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles
- The company’s pre-clinical pipeline includes programs addressing neurologic and ocular genetic diseases
